Cargando…
Author Correction: Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cells
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854403/ https://www.ncbi.nlm.nih.gov/pubmed/36670194 http://dx.doi.org/10.1038/s41598-023-28371-z |
| _version_ | 1784873110560833536 |
|---|---|
| author | Shimizu, Jun Sasaki, Tadahiro Koketsu, Ritsuko Morita, Ryo Yoshimura, Yuka Murakami, Ami Saito, Yua Kusunoki, Toshie Samune, Yoshihiro Nakayama, Emi E. Miyazaki, Kazuo Shioda, Tatsuo |
| author_facet | Shimizu, Jun Sasaki, Tadahiro Koketsu, Ritsuko Morita, Ryo Yoshimura, Yuka Murakami, Ami Saito, Yua Kusunoki, Toshie Samune, Yoshihiro Nakayama, Emi E. Miyazaki, Kazuo Shioda, Tatsuo |
| author_sort | Shimizu, Jun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9854403 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98544032023-01-22 Author Correction: Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cells Shimizu, Jun Sasaki, Tadahiro Koketsu, Ritsuko Morita, Ryo Yoshimura, Yuka Murakami, Ami Saito, Yua Kusunoki, Toshie Samune, Yoshihiro Nakayama, Emi E. Miyazaki, Kazuo Shioda, Tatsuo Sci Rep Author Correction Nature Publishing Group UK 2023-01-20 /pmc/articles/PMC9854403/ /pubmed/36670194 http://dx.doi.org/10.1038/s41598-023-28371-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Correction Shimizu, Jun Sasaki, Tadahiro Koketsu, Ritsuko Morita, Ryo Yoshimura, Yuka Murakami, Ami Saito, Yua Kusunoki, Toshie Samune, Yoshihiro Nakayama, Emi E. Miyazaki, Kazuo Shioda, Tatsuo Author Correction: Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cells |
| title | Author Correction: Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cells |
| title_full | Author Correction: Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cells |
| title_fullStr | Author Correction: Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cells |
| title_full_unstemmed | Author Correction: Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cells |
| title_short | Author Correction: Reevaluation of antibody-dependent enhancement of infection in anti-SARS-CoV-2 therapeutic antibodies and mRNA-vaccine antisera using FcR- and ACE2-positive cells |
| title_sort | author correction: reevaluation of antibody-dependent enhancement of infection in anti-sars-cov-2 therapeutic antibodies and mrna-vaccine antisera using fcr- and ace2-positive cells |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854403/ https://www.ncbi.nlm.nih.gov/pubmed/36670194 http://dx.doi.org/10.1038/s41598-023-28371-z |
| work_keys_str_mv | AT shimizujun authorcorrectionreevaluationofantibodydependentenhancementofinfectioninantisarscov2therapeuticantibodiesandmrnavaccineantiserausingfcrandace2positivecells AT sasakitadahiro authorcorrectionreevaluationofantibodydependentenhancementofinfectioninantisarscov2therapeuticantibodiesandmrnavaccineantiserausingfcrandace2positivecells AT koketsuritsuko authorcorrectionreevaluationofantibodydependentenhancementofinfectioninantisarscov2therapeuticantibodiesandmrnavaccineantiserausingfcrandace2positivecells AT moritaryo authorcorrectionreevaluationofantibodydependentenhancementofinfectioninantisarscov2therapeuticantibodiesandmrnavaccineantiserausingfcrandace2positivecells AT yoshimurayuka authorcorrectionreevaluationofantibodydependentenhancementofinfectioninantisarscov2therapeuticantibodiesandmrnavaccineantiserausingfcrandace2positivecells AT murakamiami authorcorrectionreevaluationofantibodydependentenhancementofinfectioninantisarscov2therapeuticantibodiesandmrnavaccineantiserausingfcrandace2positivecells AT saitoyua authorcorrectionreevaluationofantibodydependentenhancementofinfectioninantisarscov2therapeuticantibodiesandmrnavaccineantiserausingfcrandace2positivecells AT kusunokitoshie authorcorrectionreevaluationofantibodydependentenhancementofinfectioninantisarscov2therapeuticantibodiesandmrnavaccineantiserausingfcrandace2positivecells AT samuneyoshihiro authorcorrectionreevaluationofantibodydependentenhancementofinfectioninantisarscov2therapeuticantibodiesandmrnavaccineantiserausingfcrandace2positivecells AT nakayamaemie authorcorrectionreevaluationofantibodydependentenhancementofinfectioninantisarscov2therapeuticantibodiesandmrnavaccineantiserausingfcrandace2positivecells AT miyazakikazuo authorcorrectionreevaluationofantibodydependentenhancementofinfectioninantisarscov2therapeuticantibodiesandmrnavaccineantiserausingfcrandace2positivecells AT shiodatatsuo authorcorrectionreevaluationofantibodydependentenhancementofinfectioninantisarscov2therapeuticantibodiesandmrnavaccineantiserausingfcrandace2positivecells |